Jon Faiz Kayyem

Insider Reports History

Location
Carlsbad, CA
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Jon Faiz Kayyem
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jon Faiz Kayyem:

Form 4 holding Director

Inhibrx Biosciences, Inc.

Security class
Common Stock
Shares / value
419,360
Estimated value
$5,951,599
Report date
27 Mar 2025
Price
$14.19
Ownership
By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
Form 4 holding Director

Inhibrx Biosciences, Inc.

Security class
Common Stock
Shares / value
250,000
Estimated value
$3,548,025
Report date
27 Mar 2025
Price
$14.19
Ownership
By Jon Faiz Kayyem Revocable Trust
Form 4 holding Director

Inhibrx Biosciences, Inc.

Security class
Common Stock
Shares / value
250,000
Estimated value
$3,548,025
Report date
27 Mar 2025
Price
$14.19
Ownership
By Paige Gates-Kayyem Revocable Trust
Form 4 holding Director

Inhibrx Biosciences, Inc.

Security class
Common Stock
Shares / value
69,843
Estimated value
$991,219
Report date
27 Mar 2025
Price
$14.19
Ownership
By Child A
Form 4 holding Director

Inhibrx Biosciences, Inc.

Security class
Common Stock
Shares / value
69,843
Estimated value
$991,219
Report date
27 Mar 2025
Price
$14.19
Ownership
By Child B
Form 4 holding Director

BIODESIX INC

Security class
Restricted Stock Units
Shares / value
5,443
Estimated value
$19,608
Report date
02 Jan 2026
Price
$0.4200
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Inhibrx, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
30 May 2024
Price
$30.00
Ownership
By Child A
Form 4 holding Director

Inhibrx, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
30 May 2024
Price
$30.00
Ownership
By Child B
Form 4 holding Director

Inhibrx, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
30 May 2024
Price
$30.00
Ownership
By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
Form 4 holding Director

Inhibrx, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
$0
Report date
30 May 2024
Price
$34.12
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

BIODESIX INC

Security class
Stock Options (Right to Buy)
Shares / value
6,354
Estimated value
Report date
02 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jon Faiz Kayyem

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .